536 related articles for article (PubMed ID: 27007053)
1. Molecular and clinical significance of fibroblast growth factor 2 (FGF2 /bFGF) in malignancies of solid and hematological cancers for personalized therapies.
Akl MR; Nagpal P; Ayoub NM; Tai B; Prabhu SA; Capac CM; Gliksman M; Goy A; Suh KS
Oncotarget; 2016 Jul; 7(28):44735-44762. PubMed ID: 27007053
[TBL] [Abstract][Full Text] [Related]
2. Kinetic model for FGF, FGFR, and proteoglycan signal transduction complex assembly.
Ibrahimi OA; Zhang F; Hrstka SC; Mohammadi M; Linhardt RJ
Biochemistry; 2004 Apr; 43(16):4724-30. PubMed ID: 15096041
[TBL] [Abstract][Full Text] [Related]
3. FGF2: a novel druggable target for glioblastoma?
Jimenez-Pascual A; Mitchell K; Siebzehnrubl FA; Lathia JD
Expert Opin Ther Targets; 2020 Apr; 24(4):311-318. PubMed ID: 32174197
[No Abstract] [Full Text] [Related]
4. Targeting Drugs Against Fibroblast Growth Factor(s)-Induced Cell Signaling.
Agrawal S; Maity S; AlRaawi Z; Al-Ameer M; Kumar TKS
Curr Drug Targets; 2021; 22(2):214-240. PubMed ID: 33045958
[TBL] [Abstract][Full Text] [Related]
5. Prevalent expression of fibroblast growth factor (FGF) receptors and FGF2 in human tumor cell lines.
Chandler LA; Sosnowski BA; Greenlees L; Aukerman SL; Baird A; Pierce GF
Int J Cancer; 1999 May; 81(3):451-8. PubMed ID: 10209961
[TBL] [Abstract][Full Text] [Related]
6. Peptides derived from specific interaction sites of the fibroblast growth factor 2-FGF receptor complexes induce receptor activation and signaling.
Manfè V; Kochoyan A; Bock E; Berezin V
J Neurochem; 2010 Jul; 114(1):74-86. PubMed ID: 20374425
[TBL] [Abstract][Full Text] [Related]
7. Novel mechanisms of fibroblast growth factor receptor 1 regulation by extracellular matrix protein anosmin-1.
Hu Y; Guimond SE; Travers P; Cadman S; Hohenester E; Turnbull JE; Kim SH; Bouloux PM
J Biol Chem; 2009 Oct; 284(43):29905-20. PubMed ID: 19696444
[TBL] [Abstract][Full Text] [Related]
8. Implications of Fibroblast Growth Factors (FGFs) in Cancer: From Prognostic to Therapeutic Applications.
Dianat-Moghadam H; Teimoori-Toolabi L
Curr Drug Targets; 2019; 20(8):852-870. PubMed ID: 30648505
[TBL] [Abstract][Full Text] [Related]
9. Fibroblast Growth Factor Receptors (FGFRs) and Noncanonical Partners in Cancer Signaling.
Ferguson HR; Smith MP; Francavilla C
Cells; 2021 May; 10(5):. PubMed ID: 34068954
[TBL] [Abstract][Full Text] [Related]
10. Activation of FGF2-FGFR signaling in the castrated mouse prostate stimulates the proliferation of basal epithelial cells.
Kato M; Ishii K; Iwamoto Y; Sasaki T; Kanda H; Yamada Y; Arima K; Shiraishi T; Sugimura Y
Biol Reprod; 2013 Oct; 89(4):81. PubMed ID: 23946540
[TBL] [Abstract][Full Text] [Related]
11. Platelet factor 4 inhibits FGF2-induced endothelial cell proliferation via the extracellular signal-regulated kinase pathway but not by the phosphatidylinositol 3-kinase pathway.
Sulpice E; Bryckaert M; Lacour J; Contreres JO; Tobelem G
Blood; 2002 Nov; 100(9):3087-94. PubMed ID: 12384403
[TBL] [Abstract][Full Text] [Related]
12. Fibroblast growth factor-based signaling through synthetic heparan sulfate blocks copolymers studied using high cell density three-dimensional cell printing.
Sterner E; Masuko S; Li G; Li L; Green DE; Otto NJ; Xu Y; DeAngelis PL; Liu J; Dordick JS; Linhardt RJ
J Biol Chem; 2014 Apr; 289(14):9754-65. PubMed ID: 24563485
[TBL] [Abstract][Full Text] [Related]
13. Role of Basic Fibroblast Growth Factor in Cancer: Biological Activity, Targeted Therapies, and Prognostic Value.
Ardizzone A; Bova V; Casili G; Repici A; Lanza M; Giuffrida R; Colarossi C; Mare M; Cuzzocrea S; Esposito E; Paterniti I
Cells; 2023 Mar; 12(7):. PubMed ID: 37048074
[TBL] [Abstract][Full Text] [Related]
14. Oligomerization reduces heparin affinity but enhances receptor binding of fibroblast growth factor 2.
Safran M; Eisenstein M; Aviezer D; Yayon A
Biochem J; 2000 Jan; 345 Pt 1(Pt 1):107-13. PubMed ID: 10600645
[TBL] [Abstract][Full Text] [Related]
15. Effect of FGF/FGFR pathway blocking on lung adenocarcinoma and its cancer-associated fibroblasts.
Hegab AE; Ozaki M; Kameyama N; Gao J; Kagawa S; Yasuda H; Soejima K; Yin Y; Guzy RD; Nakamura Y; Ornitz DM; Betsuyaku T
J Pathol; 2019 Oct; 249(2):193-205. PubMed ID: 31090071
[TBL] [Abstract][Full Text] [Related]
16. Molecular Basis of the Antiangiogenic Action of Rosmarinic Acid, a Natural Compound Targeting Fibroblast Growth Factor-2/FGFR Interactions.
Pagano K; Carminati L; Tomaselli S; Molinari H; Taraboletti G; Ragona L
Chembiochem; 2021 Jan; 22(1):160-169. PubMed ID: 32975328
[TBL] [Abstract][Full Text] [Related]
17. Activation of the FGF2/FGFR1 autocrine loop for cell proliferation and survival in uveal melanoma cells.
Lefèvre G; Babchia N; Calipel A; Mouriaux F; Faussat AM; Mrzyk S; Mascarelli F
Invest Ophthalmol Vis Sci; 2009 Mar; 50(3):1047-57. PubMed ID: 19029025
[TBL] [Abstract][Full Text] [Related]
18. Structural basis for activation of fibroblast growth factor signaling by sucrose octasulfate.
Yeh BK; Eliseenkova AV; Plotnikov AN; Green D; Pinnell J; Polat T; Gritli-Linde A; Linhardt RJ; Mohammadi M
Mol Cell Biol; 2002 Oct; 22(20):7184-92. PubMed ID: 12242295
[TBL] [Abstract][Full Text] [Related]
19. The role of fibroblast growth factors and their receptors in prostate cancer.
Kwabi-Addo B; Ozen M; Ittmann M
Endocr Relat Cancer; 2004 Dec; 11(4):709-24. PubMed ID: 15613447
[TBL] [Abstract][Full Text] [Related]
20. Heparan sulfate proteoglycans function as receptors for fibroblast growth factor-2 activation of extracellular signal-regulated kinases 1 and 2.
Chua CC; Rahimi N; Forsten-Williams K; Nugent MA
Circ Res; 2004 Feb; 94(3):316-23. PubMed ID: 14684627
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
